Redifferentiation of a RET-Fusion, Radioiodine-Refractory, Differentiated Thyroid Cancer with Selpercatinib: Flip-Flop Between [¹⁸F]FDG PET/CT and ¹³¹I Posttreatment Scanning

J Nucl Med. 2025 Feb 3;66(2):330. doi: 10.2967/jnumed.124.268539.

Authors

Floriane Barbry¹, Benjamin Chevalier², Amandine Beron², Georges Lion², Samuel Boury³, Camille Marciniak⁴, Clio Baillet², Christine Do Cao⁵, Arnaud Jannin⁶

Affiliations

¹ Endocrinology Department, Tourcoing Hospital, Tourcoing, France.
² Nuclear Medicine Department, Lille University Hospital, Lille, France.
³ Radiology Department, Lille University Hospital, Lille, France.
⁴ Endocrine Surgery Department, Lille University Hospital, Lille, France; and.
⁵ Endocrinology Department, Lille University Hospital, Lille, France.
⁶ Endocrinology Department, Lille University Hospital, Lille, France arnaud.jannin@chu-lille.fr.

PMID: 39819693
DOI: 10.2967/jnumed.124.268539

No abstract available